Newsflash:
- Better T2DM Glycemic Control Achieved When Pharmacists and Physicians Collaborated
- Progeria Treatment Within Reach? Drug May Target Accelerated Aging Enzyme in Children
- Colitis Nod Puts J&J's Simponi One Step Closer to Blockbuster
- Novo Nordisk Says Completes Hemophilia Drug Trial
- Pfizer Halts Study of Lymphoma Drug Unlikely to Help Survival
- FDA Staff Says Merck's Sleep Drug Effective, Questions Dosage
Qualitest Receives FDA Approval for Levetiracetam Extended-Release Tablets, 500mg and 750mg
Endo Pharmaceuticals Press Release (07/25/12)
Qualitest Pharmaceuticals has received approval from the FDA for its Abbreviated New Drug Application for Levetiracetam extended-release tablets, 500mg and 750mg, the generic equivalent of UCB's Keppra XR. Qualitest is an operating company of Endo Health Solutions.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
